🔒 ★ European Medicines Agency Pre-Authorisation Procedural Advice
Guidance on procedural advice for users of the centralised procedure by the European Medicines Agency.
Updated daily from FDA, EMA, ICH and leading publishers
The pharma industry's research library
Curated regulatory guidance, clinical analyses, and market reports. AI-summarized, editor-reviewed, instantly downloadable.
33whitepapers
8publishers
6regions
Dailyupdates
★ Featured this week
Hand-picked by our editorial team 🔒 ★ Browse the library
33 results 🔒 ★ European Medicines Agency Pre-Authorisation Procedural Advice
Guidance on procedural advice for users of the centralised procedure by the European Medicines Agency.
Strategies to Enhance Recruitment of Female Participants to Cardiovascular Research
This consensus document outlines strategies to increase female representation in cardiovascular clinical trials, addressing significant under-representation of women.
British Society of Gastroenterology Guidelines on Inflammatory Bowel Disease in Adults: 2025
The updated BSG guidelines emphasize the necessity of ileocolonoscopy for IBD diagnosis and advocate for immunomodulators in all patients.
Barriers and Facilitators to Use of Digital Health Tools by Healthcare Practitioners
This study identifies key barriers and facilitators impacting healthcare practitioners' use of digital health technologies during and before the COVID-19 pandemic.
🔒 Agentic AI for Pharma Launches: Access & Engagement
Agentic AI can enhance pharma launches by improving market access and HCP engagement, with potential efficiency gains of up to 80%.
🔒 Ensuring Compatibility for GLP-1-based Drugs
The rise of GLP-1 agonists like Semaglutide demands innovative ready-to-use cartridges to enhance delivery efficiency and reduce costs in obesity treatment.
🔒 AI Biologics Design: Chai Discovery & Eli Lilly Partnership
Eli Lilly's partnership with Chai Discovery aims to revolutionize biologic drug design using AI, potentially achieving hit rates of 20% in antibody development.
🔒 Cigna Medical Coverage Policy: Acupuncture
Cigna's updated policy outlines conditions for acupuncture coverage, including migraine and musculoskeletal pain, effective April 2026.
🔒 Patient Mastering as Enterprise Infrastructure
Effective patient mastering is crucial for healthcare organizations to ensure accurate patient journeys and reliable analytics, impacting strategic decisions and financial outcomes.
🔒 Medicare Risk Arrangement and Use and Outcomes Among Physician Groups
At-risk Medicare Advantage arrangements show higher quality and efficiency compared to fee-for-service models, impacting care delivery for beneficiaries.
🔒 From Automotive to MedTech: Proven Software Development Practices
This whitepaper outlines how MedTech can leverage automotive software development practices to enhance compliance and accelerate innovation cycles.
🔒 Lilly's Weight-Loss Pill Approved, Sparking Competition with Novo Nordisk
Eli Lilly's daily weight-loss pill received FDA approval, setting the stage for a competitive battle with Novo Nordisk's Wegovy in the $70 billion GLP-1 market.
🔒 Radiation Therapy: Fractionation, Image-Guidance, and Special Services (Idaho Only)
This policy outlines medically necessary radiation therapy protocols for conditions like breast cancer and lung cancer, effective April 1, 2026.
🔒 Agentic AI in Pharma: Merck & Google Cloud $1B Partnership
Merck's $1 billion partnership with Google Cloud aims to deploy agentic AI to transform drug discovery and boost productivity across its global enterprise.
🔒 La Negoziazione del Prezzo dei Farmaci Oncologici in Italia
This whitepaper analyzes the market benchmark role in negotiating oncology drug prices in Italy, highlighting key implications for clinical practice.
🔒 The Patient Confusion Crisis
Pharma faces a $5B crisis as 35-40% of patients abandon specialty prescriptions. Misinformation from social media is eroding treatment adherence.
Clinical Appropriateness Guidelines for Imaging of the Chest
This whitepaper outlines the clinical appropriateness guidelines for chest imaging, aimed at improving patient care and standardizing practices.
Drug Testing for Substance Use and Pain Management
This medical policy outlines guidelines for urine drug testing in pain management and substance use treatment.